15th International Conference on Biomedical Engineering and Biotechnology
The 15th International Conference on Biomedical Engineering and Biotechnology (ICBEB 2026)will be held on November 7-9, 2026 in Hong Kong,
15th International Conference on Biomedical Engineering and Biotechnology
The 15th International Conference on Biomedical Engineering and Biotechnology (ICBEB 2026)will be held on November 7-9, 2026 in Hong Kong,
Tailoring cyclodextrin platforms for nanomolar range fluorescence detection of 1-hydroxypyrene as biomarker of polycyclic aromatic hydrocarbons
Polycyclic aromatic hydrocarbons (PAHs) are widespread combustion-derived pollutants, and 1-hydroxypyrene (1HOPy) is the standard biomarker used to track human exposure
Cyclodextrins Meet Spicy Food: HOOAGO
Spicy food is loved around the world, but the burning sensation that follows can be less enjoyable. An interesting new
HPBCD-enhanced Vaginal Hydrogel: Innovative Treatment for Menopause Symptoms
This study developed a new vaginal hydrogel to treat genitourinary syndrome of menopause, aiming to improve drug retention and patient
Association of Sugammadex Exposure with Venous Thrombosis Risk Following Primary Total Knee Arthroplasty: A Multi-Institutional Retrospective Analysis
Purpose: Although sugammadex may promote earlier postoperative mobilization and transiently affect coagulation parameters, its association with the risk of venous
Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition”
The Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition” will be published in the International Journal of Molecular Sciences
Cyclodextrins hit the golf course seven years ago — and they are still there
Golf balls may look simple, but they are highly engineered products. Their performance depends on carefully designed combinations of cores,
Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
Researchers from Türkiye developed GE11-functionalized curcumin/carboxymethyl-β-cyclodextrin (Cur/CM-βCD) supramolecular assemblies, using GE11 as an EGFR-targeting peptide, to enhance the therapeutic potential
REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
A new chapter in targeted cancer therapy On July 14, 2026, the U.S. FDA approved REVTORPYK™ (gedatolisib), developed by Celcuity,
Reducing Cholesterol with β-CDP: Insights for NPC and AD
Niemann–Pick disease type C (NPC) and Alzheimer’s disease (AD) are neurodegenerative disorders characterised by cognitive dysfunction and neurological impairment. In